Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycyrrhizin for PONV in Breast Surgery
NCT04742660Completed
- Sponsor
- Konkuk University Medical Center
- Start
- May 2021
- Primary completion
- Mar 2022
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of glycyrrhizinate in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Konkuk University Medical Center. Primary endpoint: Incidence of Postoperative Nausea and Vomiting at 24 hours. Started May 2021; status: completed.
02
Drugs
glycyrrhizinate
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT04742660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04742660.